Stock screener

AMRN

Conviction 45HealthcareScan · Thu, Jun 25, 2026
AMRN$16.37-0.24%
ResistanceSupportVol 14
63 bars
Vol MA14 109.79K
Mar 26Apr 14May 1May 19Jun 8Jun 25
AMARIN CORP PLCUKPHARMACEUTICAL PREPARATIONSwww.amarincorp.com
Price16.37
Change-0.24%
Gap+1.01%
Rel volume1.15×
Avg volume103.79K
Avg $ vol1.56M
SMA 2015.04
SMA 5014.73
SMA 20015.41
Price vs 50+11.13%
Price vs 200+6.24%
MA stackmixed
50/200 cross
Supertrendup · 14.21
RSI (14)69
MACD hist0.17
MACD cross
Stoch %K / %D74 / 72
ADX (14)26
+DI / −DI27 / 10
RSI divergence
MACD divergenceBullish
ATR %+4.56%
ADR %4.82%
52w high20.25
52w low13.50
From 52w high-19.16%
Above 52w low+21.26%
New 52w highNo
SqueezeOff
Bollinger width20.69%
%B0.93
Donchian pos75.89%
Donchian high17.25
Donchian low13.60
AVWAP (52w high)15.33
vs AVWAP high+6.81%
AVWAP (52w low)14.83
vs AVWAP low+10.35%
OBV trendUp
Chaikin MF (20)-0.19
Today vs 20d1.15×
Avg vol (14d)109.79K
Avg vol (20d)103.79K
Avg $ vol (20d)1.56M
Market cap6.23M
RS 3m (vs SPY)+1.15%
RS 6m (vs SPY)+11.18%
RS line new highNo
Trend template4/8
Technical rank78.6
1 week+3.80%
1 month+14.48%
3 months+11.51%
6 months+20.37%
1 year+2.09%
YTD+19.31%
P/E-0.16
P/B0.01
P/S0.03
P/FCF0.96
EPS-0.0900
Div yield
ROE-8.63%
ROA-6.01%
Debt/Eq0.02
Current3.48
EV/EBITDA2.31
Gross margin56.57%
Net margin-18.16%
Rev growth-6.55%
EPS growth52.79%
Price target
Target upside
Analyst rating
Institutional
Ent. value-115.95M
Revenue45.13M
Net income-10.51M
Gross profit17.77M
Free cash flow6.48M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out20.97M
Employees80
ListedThu, Apr 1, 1993
Free float380.69K
Float %100.0%
Short interest624.09K
Days to cover14.8d
Short volume31.9%
Squeeze score67 / 100
Next earningsWed, Jul 29, 2026 (34d)
EPS forecast−$0.21 · 1 est
Last EPS vs est
Last surprise
Setup gradeC
Conviction45 / 100
Pattern quality
Tech rank78.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance16.42
Support13.28
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AMRN

All disclosures →
No recent disclosed trades by Congress in AMRN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AMRN · 7 buys · 3 sells

InsiderSideShares
Bonfiglio Patrice Eadon
Director · American Depositary Shares · 2026-04-18
Exercise838
Bonfiglio Patrice Eadon
Director · American Depositary Shares · 2026-04-18
Tax403
Bonfiglio Patrice Eadon
Director · Restricted Stock Unit · 2026-04-18
Exercise838
Sullivan Diane E.
Director · American Depositary Shares · 2026-04-18
Exercise838
O'Connor Oliver
Director · Restricted Stock Unit · 2026-04-18
Exercise838
Odysseas Kostas D
Director · Restricted Stock Unit · 2026-04-18
Exercise838
Horn Keith
Director · American Depositary Shares · 2026-04-18
Exercise838
Sterling Louis III
Director · American Depositary Shares · 2026-04-18
Tax403
Cohen Paul
Director · American Depositary Shares · 2026-04-18
Exercise838
O'Connor Oliver
Director · American Depositary Shares · 2026-04-18
Tax438

SEC filings

EDGAR filings in AMRN

EDGAR →

No recent SEC filings on file for AMRN.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.